Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling. - Test2 - elhamkhani - TriplyDB

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

http://www.wikidata.org/entity/Q37212440

about

The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs Activation of D1/5 Dopamine Receptors: A Common Mechanism for Enhancing Extinction of Fear and Reward-Seeking Behaviors Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus Cell signaling underlying epileptic behavior.Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2 The role of dopamine signaling in epileptogenesis.Effects of ERK1/2 kinases inactivation on the nigrostriatal system of Krushinsky-Molodkina rats genetically prone to audiogenic seizures.Dopaminergic modulation of low-Mg²⁺-induced epileptiform activity in the intact hippocampus of the newborn mouse in vitro.Repeated stimulation of dopamine D1-like receptor and hyperactivation of mTOR signaling lead to generalized seizures, altered dentate gyrus plasticity, and memory deficits.Linalool from rosewood (Aniba rosaeodora Ducke) oil inhibits adenylate cyclase in the retina, contributing to understanding its biological activity.

P2860

Q26801864-7069BDD7-073E-4C63-A01F-3A3323AA6626 Q27315950-D178322B-D482-492B-B8B8-8EA39622A54F Q28074736-4E37F3E4-D8DF-4AD4-868A-0E1AFF6A3094 Q28272006-9A4F2C77-5E6F-4C36-961C-34BFE7268AA5 Q33894750-2A160A14-8146-4202-85B5-81C5D1BC9D28 Q35151927-867C217E-F3C7-435F-B880-E3BD66C6ED65 Q35574583-14EB7DD3-3008-4DD9-BE17-DCBEC287C7B9 Q37176694-ED89CF35-916A-4851-A038-CE343512D99B Q42512829-4D063F5E-5BC1-4CC9-8695-13260C4D4BEB Q48467168-DDDF6885-4C9F-422A-AE3D-3171110DE516 Q48648016-5AA595A1-58C9-44C8-8450-D306793E41A7 Q52719978-387D6A5C-4939-4B9D-BB04-55F087B63A7A

P2860

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

http://www.wikidata.org/entity/Q37212440

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@en

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@nl

type

label

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@en

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@nl

prefLabel

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@en

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@nl

P1433

Q37212440-459AA371-810C-413F-B127-D2120D72FE56

P1476

Q37212440-35A0A87A-D9E0-43DB-961E-4E0D42CDB083

P2093

Q37212440-0E3FF994-AB54-40CE-950E-12DF0646A96E

Q37212440-208D3860-9C77-43E1-B9F5-AB831B98BB31

Q37212440-21A328AA-6AEF-4D6A-A59A-81A6BD8E4CEC

Q37212440-3A94F3AA-770D-4AC7-8CFF-03FB86073FD5

Q37212440-75F94EC7-3ADD-45AB-9C13-9CD70FF3D32C

Q37212440-7B403078-D5F6-4D9C-9849-76CA184662C9

Q37212440-960C4C57-9587-47D5-A361-0CC209FF140C

Q37212440-D4F617A2-68B1-4CF9-A3B2-A9527B5FCBE9

Q37212440-DA48890D-B885-4EE5-8492-CB32D9978315

P2860

Q37212440-0BC44715-3684-4C4C-B426-9A3A48DDA195

Q37212440-0EC3BDF0-92C0-48B5-A116-D8DAF6E8D1E4

Q37212440-15C8BDF4-4C74-48BB-B88E-7DAC358CAA95

Q37212440-172C0468-3D4C-49F5-80B8-6DB4BC2A31F4

Q37212440-1800C08A-9E86-4D50-B672-6C2409F2CE71

Q37212440-1EA3EBDA-0258-4BD5-934C-96DDC5D4F739

Q37212440-24192A5D-BA87-47AD-8A80-7A04BAE19913

Q37212440-269A92CB-1FA4-4AB4-B674-62378CAE05EC

Q37212440-32036258-9644-4456-B6BE-342787F142CC

Q37212440-35B5D3D1-C886-42EF-ABB5-F296E9E98A1F

P304

Q37212440-F139932F-356B-4CA4-B2D8-64DCD0272BDA

P31

Q37212440-40DA6762-F166-4E5A-8B44-89164DAC48B7

P356

Q37212440-54D2418C-DBE2-4003-A134-0BC402238313

P433

Q37212440-4B89C823-7239-4F6F-B0CB-12C15305F93E

P478

Q37212440-0AB93A9C-81B5-4094-B2FF-B83531AEE5EA

P50

Q37212440-1CA64B66-4D7E-409D-859B-EAE419BA84B6

Q37212440-553FC695-902F-466D-8D95-04220949FA56

Q37212440-829F691D-F180-461A-82B5-28C0CA38A575

Q37212440-F7095D6A-D30C-4750-9951-3C6CCFA9BE72

P577

Q37212440-7C802024-A478-4ADB-A988-9D90426ED9AB

P5875

Q37212440-CF5A52C7-A13D-481B-A414-6CCC1041D25C

P698

Q37212440-8AB45536-3AA7-42E2-86AE-095C21978D8F

P921

Q37212440-3e4c9e9a-0c35-4248-955b-2582441304fe

P932

Q37212440-C18C9369-BBE0-45C8-BC95-C65CF29CC84B

P356

J.NEUROPHARM.2008.02.011

P1433

Neuropharmacology

P1476

Dopamine D1 vs D5 receptor-dep ...... 1/2 and GluR1-AMPA signalling.

@en

P2093

Allen A Fienberg

http://www.w3.org/2001/XMLSchema#string

Anthony Kinsella

http://www.w3.org/2001/XMLSchema#string

David R Sibley

http://www.w3.org/2001/XMLSchema#string

Gerard J O'Sullivan

http://www.w3.org/2001/XMLSchema#string

Gilberto Fisone

http://www.w3.org/2001/XMLSchema#string

John Drago

http://www.w3.org/2001/XMLSchema#string

John L Waddington

http://www.w3.org/2001/XMLSchema#string

Kerstin Hakansson

http://www.w3.org/2001/XMLSchema#string

Mario Clementi

http://www.w3.org/2001/XMLSchema#string

P2860

DARPP-32 mediates the actions of multiple drugs of abuse

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission

D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation

Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice

Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive

Neuroprotective role of dopamine against hippocampal cell death

Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice

Altered striatal function in a mutant mouse lacking D1A dopamine receptors

P304

1051-1061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2008.02.011

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5485662

http://www.w3.org/2001/XMLSchema#string

P698

18367215

http://www.w3.org/2001/XMLSchema#string

P921

P932

3789368

http://www.w3.org/2001/XMLSchema#string